SCHEMBL7021263

SCHEMBL7021263

CC([N])N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylamine SCHEMBL30440281 0.72
Isopropylamine SCHEMBL19813885 0.72
SCHEMBL22719 0.72
Isopropylamine SCHEMBL2909 0.72
SCHEMBL137217 0.72
SCHEMBL1773891 0.67
Isopropylamine SCHEMBL11167187 0.67
Ethane SCHEMBL7149441 0.67
Isopropylamine SCHEMBL2302157 0.67
Isopropylamine SCHEMBL20769333 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0838217-B1 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI SYNTHELABO (FR) 2003-01-15 EP disclosed
EP-0666847-B1 TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY ALLELIX BIOPHARMA (CA) 1998-06-17 EP disclosed
EP-0758320-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1997-02-19 EP disclosed
US-5504101-A TRYPTAMINE ANALOGS ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1996-04-02 US disclosed
US-5496957-A 5-HYDOXYTRYPTAMINE VIRGINIA COMMONWEALTH UNIVERSITY (US) 1996-03-05 US disclosed
WO-1995030655-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-11-16 WO disclosed
EP-0666847-A1 TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY Allelix Biopharmaceuticals Inc. (CA) 1995-08-16 EP disclosed
WO-1995006638-A1 TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-03-09 WO disclosed